Floundering private sales of vaccine in India deal blow to Russia’s Sputnik V
India is a major production centre of Sputnik V, with planned capacity of about 850 million shots a year, and low domestic uptake…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
World leaders thank India for COVID-19 shipments
Several world leaders expressed their gratitude to India and other nations for the help provided through exports of vaccines and…
MSF demands newest COVID-19 treatment recommended by WHO must be accessible to all
Regeneron, which produces the two-drug treatment cocktail casirivimab/imdevimab, must ensure affordable pricing and adequate…
TechInvention claims positive outcomes of its SARS-CoV-2 vaccine
The study showed a two-fold and a 20-fold increase in the IgG titre value (compared to adjuvant control) at a dose of 50 mcg/0.5ml…
US FDA authorises third dose of Pfizer COVID-19 vaccine for older Americans
The booster dose is to be administered at least six months after completion of the second dose, and the authorisation would…
Britain begins trial of multi-variant COVID-19 vaccine booster
The trial, involving GRT-R910, has been launched by the US pharmaceutical company Gritstone in collaboration with the University…
Clover says its COVID-19 vaccine candidate 67 per cent effective in large trial
The company has a deal to supply up to 414 million doses of its COVID-19 vaccine through the global vaccine sharing scheme COVAX
Serum Institute to invest $68 million in Oxford Biomedica
As part of the deal, Serum Life Sciences, a unit of SII, will pick up a 3.9 per cent stake in Oxford Biomedica
SII to supply almost 22 crore doses of Covishield vaccine to Centre in October
The Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month
India set to get J&J COVID vaccine doses next month
India's drug regulator last month gave emergency authorisation to the J&J vaccine, whether imported or locally filled and…
Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
The companies said the vaccine generated an immune response in the five-to-11 year olds in their phase-II/III clinical trial that…
India to resume export of surplus COVID vaccines in October-December quarter
Addressing the media, Health Minister said the government will receive over 30 crore doses of COVID-19 vaccines in October and…
Booster shots necessary to beat COVID-19 virus, says Dr Fauci
Pfizer made the proposal in a 52-page presentation to the US FDA, which included data from the recent Israeli study, which showed…
US sees surge in demand for monoclonal antibodies to treat COVID
Overall, the demand for monoclonal antibody treatment, lab-made antibodies given to a person that help their immune system stop…
WHO might give nod for Covaxin this month
The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s…
Everest to bring Canadian biotech’s potential COVID shots to China and other markets
Interim data from an early-stage human trial outside China has showed Providence's shot PTX-COVID19-B was safe and produced strong…
WHO asks for more data on Sputnik V for EUL
According to WHO website, though several meetings were held as part of the process for EUL, the status of assessment column says…
Takeda to manufacture 150 million doses of Novavax for Japan’s MHLW
The details of the terms and conditions of the agreement are confidential
EMA studying data on Pfizer’s COVID-19 vaccine booster dose
The drugmakers filed an application with the European Medicines Agency (EMA) which said it would carry out a speedy evaluation of…
Panacea Biotec supplies maiden shipment of Sputnik V’s second component produced in India
Doses of the second component of Sputnik V have been manufactured at the Panacea Biotec’s state-of-the-art vaccine manufacturing…